# Cardiff Oncology, Inc.: Form 8-K, filed Jun 3, 2024

- Company: [Cardiff Oncology, Inc.](/companies/crdf.md) (CIK 1213037)
- Form: 8-K
- Filed: 2024-06-03
- Accepted by EDGAR: Jun 3, 2024, 16:03 ET
- Period: 2024-05-30
- Accession: 0001628280-24-026295
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1213037/000162828024026295/crdf-20240530.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1213037/000162828024026295/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1213037/000162828024026295/crdf-20240530.htm

Filed Jun 3, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-026295. Last ingested by Listed: Nov 13, 2026, 16:10 ET. No prices; not investment advice.
